
EU Puts Big Tech in Hot Seat & NBA Champs For Sale?
Morning Brew Daily
00:00
Celtics Sale and Pharma Patent Controversies
This chapter explores the anticipated $5 billion sale of the Boston Celtics, highlighting the significant increase in NBA franchise valuations and the impact of a monumental media rights deal. It also examines the ongoing FTC investigation into pharmaceutical patent practices, revealing tensions between innovation protection and market competition.
Play episode from 06:50
Transcript


